Literature DB >> 26437066

The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.

Y Kong1, Y-T Wang1, Y Hu1,2, W Han1, Y-J Chang1, X-H Zhang1, Z-F Jiang2,3, X-J Huang1,2.   

Abstract

Poor graft function (PGF), including early and late PGF, is a serious complication following allotransplant. We recently reported that bone marrow microenvironment abnormalities may occur in cases of late PGF. Whether these abnormalities occur in early PGF remains unknown. To answer this question, we performed a nested case-control study comparing cellular elements of the bone marrow microenvironment in 10 subjects with early PGF, 30 subjects with late PGF and 40 subjects without PGF. Bone marrow endosteal cells, perivascular cells and endothelial cells were analyzed by flow cytometry and by hematoxylin-eosin and immunohistochemical staining in situ. Subjects with early and late PGF had similar abnormalities in these cell types compared with transplant recipients without PGF. However, none of the aforementioned elements of the bone marrow microenvironment were significantly different between early and late PGF patients. Our data suggest that similar abnormalities in the bone marrow microenvironment may occur in early and late PGF post allotransplant. Cellular approaches, such as the administration of mesenchymal stem cells, promise to be beneficial therapeutic strategies in patients with early or late PGF.

Entities:  

Mesh:

Year:  2015        PMID: 26437066     DOI: 10.1038/bmt.2015.229

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  26 in total

1.  Selection of controls in case-control studies. III. Design options.

Authors:  S Wacholder; D T Silverman; J K McLaughlin; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

2.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation.

Authors:  Yusuke Shono; Satoshi Ueha; Yong Wang; Jun Abe; Makoto Kurachi; Yoshihiro Matsuno; Tatsuki Sugiyama; Takashi Nagasawa; Masahiro Imamura; Kouji Matsushima
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

Review 4.  Haploidentical hematopoietic transplantation: current status and future perspectives.

Authors:  Yair Reisner; David Hagin; Massimo F Martelli
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

5.  CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.

Authors:  Evgeny Klyuchnikov; Jean El-Cheikh; Andreas Sputtek; Michael Lioznov; Boris Calmels; Sabine Furst; Christian Chabannon; Roberto Crocchiolo; Claude Lemarié; Catherine Faucher; Ulrike Bacher; Haefaa Alchalby; Thomas Stübig; Christine Wolschke; Francis Ayuk; Marie-Luise Reckhaus; Didier Blaise; Nicolaus Kröger
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-07       Impact factor: 5.742

6.  Graft failure in the modern era of allogeneic hematopoietic SCT.

Authors:  R Olsson; M Remberger; M Schaffer; D M Berggren; B-M Svahn; J Mattsson; O Ringden
Journal:  Bone Marrow Transplant       Date:  2012-12-10       Impact factor: 5.483

7.  In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification.

Authors:  Yu Wang; De-Pei Wu; Qi-Fa Liu; Ya-Zhen Qin; Jing-Bo Wang; Lan-Ping Xu; Yan-Rong Liu; Hong-Hu Zhu; Jia Chen; Min Dai; Xiao-Jun Huang
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

8.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

9.  Endothelial and perivascular cells maintain haematopoietic stem cells.

Authors:  Lei Ding; Thomas L Saunders; Grigori Enikolopov; Sean J Morrison
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

10.  Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.

Authors:  Ying-Jun Chang; Xiang-Yu Zhao; Lan-Ping Xu; Xiao-Hui Zhang; Yu Wang; Wei Han; Huan Chen; Feng-Rong Wang; Xiao-Dong Mo; Yuan-Yuan Zhang; Ming-Rui Huo; Xiao-Su Zhao; Kong Y; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388

View more
  15 in total

1.  Early and late graft-failure after transplants.

Authors:  R P Gale
Journal:  Bone Marrow Transplant       Date:  2015-11-02       Impact factor: 5.483

2.  Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation.

Authors:  Yuan Kong; Yu Wang; Yuan-Yuan Zhang; Min-Min Shi; Xiao-Dong Mo; Yu-Qian Sun; Ying-Jun Chang; Lan-Ping Xu; Xiao-Hui Zhang; Kai-Yan Liu; Xiao-Jun Huang
Journal:  Blood Adv       Date:  2019-04-23

Review 3.  Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation.

Authors:  Yan Man; Zhixiang Lu; Xiangmei Yao; Yuemin Gong; Tonghua Yang; Yajie Wang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

4.  Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.

Authors:  Kaito Harada; Shigeo Fuji; Sachiko Seo; Junya Kanda; Toshimitsu Ueki; Fumihiko Kimura; Koji Kato; Naoyuki Uchida; Kazuhiro Ikegame; Makoto Onizuka; Ken-Ichi Matsuoka; Noriko Doki; Toshiro Kawakita; Yasushi Onishi; Shingo Yano; Takahiro Fukuda; Minoko Takanashi; Yoshinobu Kanda; Yoshiko Atsuta; Masao Ogata
Journal:  Bone Marrow Transplant       Date:  2020-02-12       Impact factor: 5.483

5.  Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.

Authors:  Yuan Kong; Yang Song; Yue Hu; Min-Min Shi; Yu-Tong Wang; Yu Wang; Xiao-Hui Zhang; Lan-Ping Xu; Kai-Yan Liu; Hong-Kui Deng; Xiao-Jun Huang
Journal:  Oncotarget       Date:  2016-05-24

6.  Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.

Authors:  Yuan Kong; Yu-Tong Wang; Xie-Na Cao; Yang Song; Yu-Hong Chen; Yu-Qian Sun; Yu Wang; Xiao-Hui Zhang; Lan-Ping Xu; Xiao-Jun Huang
Journal:  J Transl Med       Date:  2017-03-14       Impact factor: 5.531

Review 7.  Update of the "Beijing Protocol" haplo-identical hematopoietic stem cell transplantation.

Authors:  Meng Lv; Ying-Jun Chang; Xiao-Jun Huang
Journal:  Bone Marrow Transplant       Date:  2019-08       Impact factor: 5.483

Review 8.  Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Stavroula Masouridi-Levrat; Federico Simonetta; Yves Chalandon
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

9.  Validation of Housekeeping Genes as Reference for Reverse-Transcription-qPCR Analysis in Busulfan-Injured Microvascular Endothelial Cells.

Authors:  Wen Ju; Alhaji Osman Smith; Tiantian Sun; Pingping Zhao; Yan Jiang; Lu Liu; Ting Zhang; Kunming Qi; Jianlin Qiao; Kailin Xu; Lingyu Zeng
Journal:  Biomed Res Int       Date:  2018-10-02       Impact factor: 3.411

10.  Autophagy in endothelial cells regulates their haematopoiesis-supporting ability.

Authors:  Zhong-Shi Lyu; Xie-Na Cao; Qi Wen; Xiao-Dong Mo; Hong-Yan Zhao; Yu-Hong Chen; Yu Wang; Ying-Jun Chang; Lan-Ping Xu; Xiao-Hui Zhang; Yuan Kong; Xiao-Jun Huang
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.